Related Experiment Videos
Chromatic-contrast threshold impairment in diabetes
S J Tregear1, P J Knowles, L G Ripley
1Department of Vision Science, Glasgow Caledonian University, UK.
Eye (London, England)
|January 1, 1997
Summary
Diabetic patients show reduced color vision, particularly in blue-yellow perception, even without retinopathy. This deficit is linked to lens yellowing, not cone damage, suggesting automated tests for diabetic retinopathy screening.
Area of Science:
- Ophthalmology
- Medical Diagnostics
- Vision Science
Background:
- Diabetes mellitus can lead to acquired color vision deficits.
- Diabetic retinopathy is a common complication affecting vision.
- Previous hypotheses suggested cone system damage in diabetic patients.
Purpose of the Study:
- To investigate acquired color vision deficits in diabetic patients using automated chromatic contrast testing.
- To compare color vision in diabetics with and without retinopathy to control groups.
- To explore associations between color vision deficits and diabetes-related factors.
Main Methods:
- Prospective study of 305 diabetic eyes using a CRT-based chromatic contrast test.
- Measurement of red/green and tritan color vision thresholds.
- Comparison with age-matched and lens-equated normal control data.
- Analysis of correlations with age, disease duration, macular edema, and ischemia.
Main Results:
- Diabetics exhibited significantly reduced chromatic contrast thresholds compared to controls, even without retinopathy.
- The predominant deficit was tritanopic (blue-yellow axis).
- Tritan deficits in diabetics without retinopathy were explained by lens yellowing, not cone damage.
- Red/green deficits and tritan deficits correlated with retinopathy severity.
Conclusions:
- Automated chromatic contrast testing can detect early color vision changes in diabetics.
- Lens yellowing, not blue cone damage, likely explains tritan deficits in diabetics.
- These findings support the use of automated color vision tests in diabetic retinopathy screening.